EASAPS/ESAPS Statement on reports of SCC associated with breast implants (BIA-SCC)
Dear Members, On 8th September of 2022, the U.S. Food and Drug Administration (FDA) posted a Safety Communication on their website (https://www.fda.gov/medical-devices/safety-communications/breast-implants-reports-squamous-cell-carcinoma-and-various-lymphomas-capsule-around-implants-fda), informing the public about reports of cancers, including breast implant associated squamous cell carcinoma (BIA-SCC) and various lymphomas (besides BIA-ALCL) in the capsule surrounding breast implants. BIA-SCC has been reported as occurring in the capsule around both textured and smooth surfaces as well as in the capsule around both silicone and saline filled breast implants. Case reports, although very rare, have been published for several decades. So far, 26 cases have been reported worldwide. Based upon the literature,…
-
Mar 27, 2023
-
by Nora Nugent
